The Valley Desk

NCT03032380 · Interventional trial

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

Overall registry status Completed

Phase 3

Conditions Healthcare-associated Pneumonia (HCAP), Hospital Acquired Pneumonia (HAP), Ventilator Associated Pneumonia (VAP)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov